Corporate Banner
Satellite Banner
Technology Networks Header
Monday, October 20, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Thin Film Thickness Measurements of Sub-Micron Sampling Areas
Friday, February 28, 2014
CRAIC FilmPro™ software is used with CRAIC Technologies microspectrometers to measure the thickness of thin films of microspot areas in both reflectance and transmission.

Rigaku Introduces Newest Instruments at Pittcon 2014
Wednesday, February 26, 2014
Company exhibits its benchtop lines of XRD and XRF instrumentation at Booth #2355.

Bruker Introduces S2 KODIAK™
Tuesday, February 25, 2014
Advanced online XRF multi-element analyzer for real-time results in mining of base metal ores and industrial minerals.

B&W Tek Announces New Addition to NanoRam® Product Line
Saturday, February 22, 2014
NanoRam FP - Designed for nondestructive identification and verification of materials.

Rugged Direct Sample Analysis by Mass Spectrometry with the DART®-QS Source
Monday, February 17, 2014
Rapid analysis with the Direct Analysis in Real Time technology provides near-instantaneous detection of drugs of abuse and contaminants.

Rigaku Wins Order for a TXRF 450mm Spectrometer
Friday, February 14, 2014
Company wins order from a global Semiconductor Equipment Manufacturer.

Rigaku Publishes New Method for Analysis of Iron, Calcium and Silicon Oxides
Friday, February 14, 2014
Analysis of iron in EAFS by using the Rigaku NEX QC+ EDXRF analyzer.

PANalytical’s Epsilon 3X Benchtop Spectrometers at AXAA Conference
Tuesday, February 11, 2014
New Epsilon 3X benchtop spectrometers provide ultimate light-element performance.

PANalytical’s Epsilon 3X Benchtop Spectrometers Outperform Light-element Analysis
Monday, February 10, 2014
The spectrometers deliver outstanding analytical performance right across the periodic table.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 520
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv